PANGEN BIOTECH INC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets biotechnology, chemical engineering and pharmaceuticals are BIOTECNOL SA, TIMMUNE BIOTECH INC and ABSCI LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 2 | |
#3 | Brazil | 2 | |
#4 | China | 2 | |
#5 | Republic of Korea | 2 | |
#6 | United States | 2 | |
#7 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Chemical engineering | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Fermentation | |
#4 | Separation | |
#5 | Medical preparations | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Park Jeong Soo | 7 |
#2 | Baek Kwanghee | 7 |
#3 | Yoon Jaeseung | 7 |
#4 | Byun Taeho | 5 |
#5 | Kim Ji Tai | 4 |
#6 | Hwang Hye-Yeon | 3 |
#7 | Kim Jeong Do | 3 |
#8 | Kim Dong-Jun | 3 |
#9 | Leesong Alex Inkeun | 3 |
#10 | Yoon Yeup | 3 |
Publication | Filing date | Title |
---|---|---|
US2020277401A1 | Anti-coagulation factor viii antibody and use thereof | |
WO2018111010A1 | Anti-hemocoagulation factor viii antibody and use thereof | |
KR20120112254A | Expression vector for animal cell | |
WO0248379A1 | Expression vector for animal cell containing nuclear matrix attachment region fo interferon beta |